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A VALIDATION OF MOBILE SENSING ACTIGRAPHY DEVICES FOR 
GENERATING A BIOMECHANICAL MODEL OF POSTURE 
CRAIG N. DETHERIDGE 
ABSTRACT 
 Mobile sensing actigraphy was tested and validated as a modality for computing 
dynamic posturography. Twelve healthy volunteer subjects (6 male) were administered 
risperidone and assessed for postural stability using a NeuroCom® Balance Master 
system and BioSensics® mobile sensors at baseline, 2 hours, 6 hours, and 24 hours post-
dose. A strong positive correlation was shown between BioSensics and Balance Master 
systems in a modified Sensory Organization Task, with Pearson’s r = 0.76, p < 0.001 on 
composite equilibrium scores. Strong to moderate correlations during the same task 
showed r = 0.48, p < 0.001 to r = 0.74, p < 0.001. Mobile sensing actigraphy may be a 
viable alternative to force plate posturography in assessing drug-induced postural 
instability. 
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INTRODUCTION 
 
Posturography refers to the assessment of postural control in upright stance in 
either static or dynamic conditions. Posturography, as assessed by the Balance Master 
and BioSensics systems, was compared for sensitivity and consistency. Previous studies 
have used the Balance Master system for assessment of gait and risk of fall in the elderly, 
persons with dizziness, stroke, spinal cord injury, and brain injury (Ben Achour Lebib, 
Missaoui, Miri, Ben Salah, & Dziri, 2006; Chien, Hu, Tang, Sheu, & Hsieh, 2007; Fraix, 
Gordon, Graham, Hurwitz, & Seffinger, 2013; Lemay & Nadeau, 2013; Liston & 
Brouwer, 1996; Newstead, Hinman, & Tomberlin, 2005). The BioSensics sensors were 
tested for comparability to the force plate system, as they are relatively inexpensive, more 
mobile, and potentially more robust due to using the two-link model of posturography 
rather than the inverted pendulum model.  
Risperidone (RISPERDAL®) is indicated for the treatment of schizophrenia, and 
acute manic or mixed episodes associated with Bipolar I Disorder in the United States. It 
has been proposed that risperidone's therapeutic activity in schizophrenia is mediated 
through a combination of potent D2 and serotonin Type 2A (5HT2A) receptor antagonism 
(Foster & Goa, 1998). The potent D2 antagonist is considered to improve the positive 
symptoms of schizophrenia, it causes less depression of motor activity and induction of 
catalepsy in animal models than classical antipsychotics, and a potent 5HT2A antagonism 
has been shown to reverse deficits in several in vivo animal models predictive of novel 
antipsychotic activity (Megens, Awouters, & Niemegeers, 1988). Balanced central 
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serotonin and dopamine antagonism may reduce extrapyramidal side-effect liability. 
Antagonism at receptors other than D2 and 5HT2 may explain some of the other effects of 
risperidone.  
Further, risperidone has been chosen in this study since it represents a compound 
with a well-characterized dose to D2 receptor occupancy-to-EPS relationship. It is 
expected that risperidone 2 mg will lead to D2 occupancy of between 65-75% (Yamada, 
et al., 2002). These doses are considered appropriate since EPS liability relative to D2 
receptor occupancy is generally associated with D2 occupancy >80%, and the objective is 
to validate mobile sensing actigraphy as a surrogate for force plate Computed Dynamic 
Posturography. 
It is hypothesized that posturography will be a sensitive and objective means of 
detecting subtle changes in motor behavior modulated by striatal dopamine receptor 2 
subtype (D2) receptor occupancy associated with risperidone. The purpose of this study is 
to evaluate within- and between-subject variability and mean change on multiple 
modalities to assess mobile sensing. Posturography will be calculated via force plate 
(Balance Master™, NeuroCom, Pleasanton CA) and mobile sensing actigraphy 
(BalanSens™, BioSensics LLC, Cambridge MA).   
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METHODS 
 
 The study population consisted of a single cohort consisting of twelve (12) 
healthy individuals (6 males) ranging from 18-34 years of age with 2 dropouts (Table 1).  
Individuals who responded to recruitment materials underwent a screening phone 
interview consisting of a brief description of the study and asked questions to determine 
their eligibility. Potential subjects gave their formal verbal consent prior to the phone 
screening, and had an opportunity to ask questions about the study. Those who met the 
inclusion criteria and none of the exclusion criteria were invited to participate in the 
study. Eligible participants where scheduled for an in-person appointment to sign the 
consent form and complete the study. All study procedures were approved by the 
Institutional Review Board at The Boston 
University School of Medicine, and 
pharmaceuticals were obtained from the 
Investigational Research Pharmacy at 
Boston Medical Center. 
All experiments took place in a 
dedicated lab space located at 650 Albany Street, Boston MA. The posturography tasks 
were administered by a trained administrator.  Upon arriving at the Laboratory for 
Human Neurobiology, subjects reviewed and signed the Informed Consent Document, 
underwent brief intake procedures including electrocardiogram (ECG) evaluation and 
pregnancy tests (female subjects only). Subjects were excluded if their ECG showed a qT 
interval of >450ms. All subjects completed four testing sessions at Hour 0 (pre-dose 
Variable Value
Age 26	(+/-	4)
Height (68	+/-	4.6)
Weight 167.6	(+/-	33.7)
BMI 25.2	(+/-	2.4)
Table 1 Mean (+/- Standard Deviation) Age, height, 
weight, and BMI 
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baseline), Hour 2, Hour 6, and Hour 24.  Each testing session consisted of the following 
activities: blood pressure, pulse, device assignment, modified Sensory Organization Test 
(mSOT). Subjects remained at the laboratory for 7 hours after the administration of dose 
after which time subjects were released for the night to an accompanying escort. 
Subjects were provided a $10 stipend and allowed time to eat lunch in between 
scheduled tasks.  While not performing a task, subjects stayed in a private room and were 
asked to wait until the administrator notified them it was time to begin the next set of 
tasks. 
Participants were financially compensated for their time and participation in the 
study at the completion of task activities. 
Device Placement 
 During the mSOT task, the BioSensics sensors were 
placed on the lower back, and right shank (Figure 1). 
This placement allows for a 2-link biomechanical 
model to be reconstructed, offering insight into postural sway 
and center-of-mass location (Najafi, Lee-Eng, Wrobel, & 
Goebel, 2015).		
 	 The	sensors	each	weigh	25g,	have	a	sampling	 frequency	of	100	Hz,	and	use	an	accelerometer	with	a		sensitivity	of	±2g,	and	a	gyroscope	with	a	sensitivity		of	±2000	deg/s.			
Figure 1 Placement of the 
BioSensics sensors during 
mSOT. Courtesy of 
BioSensics®  
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Force Plate Equipment 
 A NeuroCom® SMART Balance Master system, 
version 9.2, was used (Figure 2). The system 
incorporates two foot plates, measuring 9 X 18 inches. 
Each foot plate rests on two force transducers to measure 
the vertical and horizontal force exerted by the left and 
right feet. The Center of Force of each foot plate is used 
to infer a vertical projection of the subject’s Center of 
Gravity (COG). The COG is assumed to be at 55% of the 
total height of the subject, and 14% of foot length in front 
of the medial maleolus bone in the ankle joint (Parker & 
West, 1973).  
Modified Sensory Organization Task Protocol 
 The mSOT assesses a subject’s ability to maintain upright posture, and calculates 
the amount of antero-posterior sway that is exhibited. During the assessment, the subject 
is secured in a safety harness and faces the surround chamber of the Balance Master 
platform. The subject is instructed to remain as still and upright as possible, with their 
arms at their sides. Dependent on the condition, the platform may be fixed or dynamic 
and the surround may be fixed or dynamic, and the subject may be instructed to close 
their eyes (Figure 3). The force plate and surround during the dynamic conditions 
Figure 2 NeuroCom® SMART 
Balance Master system. Courtesy of 
NeuroCom® 
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exhibits “sway-referencing”, or the act of moving to exactly follow the subject’s sway 
and eliminate sensory feedback of sway motion. Sway-referencing forces the subject to 
rely on other sensory modalities, such as vestibular, when the vision and/or 
proprioceptive senses are compromised. 
During the modified Sensory Organization Task, only conditions 1, 2, 4, and 5 are 
performed. Three trials of each condition, for 20 s each, are completed. If the subject 
touches the sides of the machine, looses footing, or is supported by the harness in any 
way, the trial is considered a fall. 
	
Figure 3 Sensory Organization Task Conditions. The mSOT consists of conditions 1, 2, 4, & 5. Courtesy of 
NeuroCom® 
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Calculations  
The same equations are used for the Balance Master system as are used for the 
BioSensics sensors. 
Sway Angle The antero-posterior (AP) sway is originally measured as the centimeters 
in which the COG travels forward and back. However, this sway must be normalized to 
allow for between-subject analysis due to the variability in the height of the COG due to 
subject height. To normalize sway, the AP Sway Angle is calculated using the following 
equation:  
 
 
Where Q is the AP Sway Angle, HCOG is the Height of the COG, and PCOG is the 
instantaneous position of the COG. The formula takes into account the 2.3° of forward 
lean that the human body naturally exhibits when standing erect. The small angle 
approximation by use of arcsine is accurate to within 0.5% in these use-cases, and thus 
appropriate for estimation. 
Equilibrium Score In order to quantify and differentiate “normal sway” from 
“pathological sway”, an equilibrium score is calculated. This score assesses how well the 
subject remains within the theoretical angular limits of stability of the human body, 
which is theorized to be 8 degrees forward and 4.5 degrees back. The following equation 
is used: 	 	 	 	𝑬𝒒𝒖𝒊𝒍𝒊𝒃𝒓𝒊𝒖𝒎	𝑺𝒄𝒐𝒓𝒆 = 𝟏𝟐. 𝟓° − (𝜽𝒎𝒂𝒙9𝜽𝐦𝐢𝐧)𝟏𝟐.𝟓° ∗ 100		
	8 
 The score has an inverse relationship with sway, meaning that a high score will 
depict little sway and a low score depicts much sway. A fall is considered a score of 0.  
AP Sway Velocity The Sway Velocity (SV) is the distance traveled by the COG, in 
degrees, over the time of the trial. The following equation is used: 𝑆𝑤𝑎𝑦	𝑉𝑒𝑙𝑜𝑐𝑖𝑡𝑦 = ( Σ∆𝜃 )/𝑡 
 
Where 𝜃 is the AP Sway Angle, and t is the trial time in seconds. 
Equilibrium Composite Score A composite score of each trial and each condition 
of the mSOT is comprised of a weighted average of each of the conditions, using the 
following equation: 
 𝑚𝑆𝑂𝑇	𝐶𝑜𝑚𝑝𝑜𝑠𝑖𝑡𝑒	𝑆𝑐𝑜𝑟𝑒	= 	 (Avg(SOT − 1) + 	Avg(SOT − 2) + 	Trial_1(SOT − 4) + 	Trial_2(SOT − 4)+ 	Trial_3(SOT − 4) + Trial_1(SOT − 5) + Trial_2(SOT − 5) + Trial_3(SOT− 5)/(3trials(SOT − 4) 	+ 	3	trials	(SOT − 5) 	+ 	2	trials(SOT − 1	and	SOT − 2))	 
 
RESULTS 	
Blood Pressure and Heart Rate Subjects’ mean systolic and diastolic blood pressure 
were higher at baseline than at subsequent assessments. Subjects’ mean heart rate 
remained within 2.5 bpm throughout assessment periods. Mean values are demonstrated 
in Table 2. 	
Table 2 Mean (+/- Standard Deviation) blood pressure and heart rate as assessed at sessions pre- and post-dose. 
Variable Baseline Hour	2 Hour	6 Hour	24
Systolic	blood	pressure	(mmHg) 122.8	(+/-	18.6) 119.0	(+/-	18.4) 118.0	(+/-	17.0) 117.5	(+/-	14.0)
Diastolic	blood	pressure	(mmHg) 77.5	(+/-	10.4) 71.5	(+/-	9.7) 69.8	(+/-	10.3) 71.3	(+/-	9.3)
Heart	Rate	(bpm) 76.6	(+/-	14.4) 74.2	(+/-	13.4) 77.2	(+/-	13.1) 73.5	(+/-	9.1)
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mSOT Equilibrium COMPOSITE Scores 
  
Balance Master demonstrated a general upward trend in composite equilibrium 
scores from Hour 0 to Hour 24, as shown in Figure 4. BioSensics demonstrated a reduction 
in performance at Hour 2 and Hour 6 with a general upward trend in equilibrium scores 
from Hour 0 to Hour 24.  Pearson’s Product-Moment Correlation between Balance Master 
and BioSensics composite scores demonstrated a strong positive correlation of r = 0.76, p 
< 0.001. 
 
 
	
Figure 4 mSOT Equilibrium Composite Scores for Balance Master (left) and BioSensics (right). Trial mean represented 
as a bold blue line.  Mean equilibrium scores at each time point represented by black triangles. Gray shading indicates 
the 90% confidence interval. 
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Sway Velocity 
During each condition, sway velocity increased at peak dose and initial washout 
(i.e. Hour 2 and Hour 6), suggesting a pharmacodynamic disturbance on postural stability 
(Figure 5). 
Correlations between Balance Master and BioSensics sway velocity scores were 
the following: Condition 1 r = 0.57, p < 0.001; Condition 2 r = 0.48, p = 0.001; Condition 
4 r = 0.63, p < 0.001; Condition 5 r = 0.74, p < 0.001. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  
Figure 5 Sway velocity scores for both the Balance Master (BM; top row) and BioSensics (bottom row) systems 
during the mSOT tasks. Trial mean represented as a bold blue line.  Mean equilibrium scores at each time point 
represented by black triangles. Gray shading indicates the 90% confidence interval 
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DISCUSSION 
 
 There are fundamental differences in the measurements 
collected by the NeuroCom® Balance Master system and the 
BioSensics. Most importantly is the distinction between the 
biomechanical models used to compute posturography from a fixed 
number of points. 
 The Balance Master system assumes the “inverted 
pendulum” model, as shown in Figure 6. This model assumes 
that a human’s Center of Gravity may be calculated based on 
a measurement of the Center of Pressure of the feet, and that the 
COG may be extrapolated from the angle at which the shank 
extends from the ankle. One major flaw in this assumption is the failure to acknowledge 
the role of the hip and knee in vertical posture.  
 Conversely, the BioSensics sensors in this array utilized a two-link biomechanical 
model. This model factors both ankle and hip angles to determine the Center of Gravity. 
The two-link model has been found to be more effective in accurately determining the 
trajectory of a Center of Gravity (Najafi, Lee-Eng, Wrobel, & Goebel, 2015).  
Figure 6 The inverted 
pendulum model  
of human posturography. 
Courtesy of 
NeuroCom® 
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 Although the correlation between the reference technology (force plate system) 
was not a perfect r = 1, the validity of the force plate may be brought into question. The 
assumption of validity is necessary, as force plate technology is currently the industry 
gold standard in posturography, however the lack of complete correlation should not 
insinuate insufficiency in mobile sensing technology. 	 The differences in measurement are more clearly demonstrated in the Sway 
Velocity measurement. In this study, only the antero-posterior dimension was used. A 
limitation of mobile sensing actigraphy is that the axes of measurement are dependent on 
the placement of the sensors on the body. If there is a rotation about the z-dimension, 
such as a shifting of the sensor around the shank or waist, the amount of AP sway will be 
inaccurately underestimated. This may account for the observed difference in AP Sway 
Velocity, although the correlations were still moderate (r = 0.46, p < 0.001) at worst and 
strong (r = 0.74, p < 0.001) at best. In future studies, it may prove more robust to measure 
both medio-lateral and antero-posterior sway velocity and generate a 2-dimensional 
ellipsis of sway.   During	the	mSOT	trials,	the	Balance	Master	system	assigned	a	score	of	0	to	a	fall.	This	assignment	was	necessary	as	the	force	plate	is	unable	to	properly	track	COG	trajectory	if	a	foot	is	displaced	or	lifted.	The	BioSensics	sensors,	however,	were	able	to	continue	measuring	COG	displacement	when	a	subject	lifted	a	foot	or	fell.		The	portability	of	the	mobile	sensors	is	a	major	logistical	benefit	to	the	technology	over	force	plates.	In	a	purely	practical	sense,	a	force	plate	system	may	prove	unfeasible	to	fund	or	relocate	in	clinical	use.	The	mobile	sensors	have	the	
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benefit	of	fitting	in	a	suitcase.	Additionally,	mobile	sensors	have	the	possibility	of	being	used	in	a	use-case	that	would	not	allow	for	a	force	plate;	such	as	a	subject	in	motion	or	performing	an	activity	that	would	require	the	feet	to	leave	the	ground.		One	limitation	of	this	study	was	the	limited	number	of	participants.	The	confidence	intervals	exhibited	statistical	significance,	although	there	was	not	homogeneity	among	the	observed	effects	of	risperidone	on	all	participants.	For	example,	a	majority	of	subjects	demonstrated	diminished	postural	stability	at	peak	dose	and	initial	washout	(2	and	6	hours	post-dose).	However,	some	subjects	demonstrated	increased	performance	on	the	mSOT	during	these	periods.	A	possible	explanation	for	this	phenomenon	would	be	subject	variables	that	were	not	collected	at	the	time	of	recruitment,	such	as	participation	in	athletics	or	the	use	of	public	transportation	as	a	primary	means	of	commuting.	If	a	participant	was	an	athlete,	they	would	have	had	a	greater	exposure	to	activities	that	strengthen	postural	alignment	and	stability.	An	athlete	would	likely	have	greater	control	over	Center	of	Gravity	trajectory	in	comparison	to	a	non-athlete.	If	a	participant	utilized	public	transportation,	they	would	have	more	practice	with	maintaining	an	upright	posture	during	times	of	unexpected	perturbation	than	a	commuter	who	drives.	A	subway	or	bus	rider	must	learn	to	use	proprioceptive	and	visual	feedback	to	overcome	the	vestibular	sense,	in	order	to	commute	without	falling.	Another	limitation	of	the	study	was	the	absence	of	“practice	trials”.	There	is	an	insufficiency	in	the	literature	regarding	this	effect,	as	it	has	not	been	clearly	tested	or	reported.	The	learning	effect	is	a	commonly	observed	phenomenon	in	
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novel	activities,	which	may	have	taken	place	during	this	study.	Some	participants	steadily	performed	better	during	each	assessment,	while	the	expected	pharmacodynamic	effect	would	have	been	decreased	performance	while	under-drug	and	a	return	to	baseline	after	washout.	An	experiment	to	test	the	practice	effect	is	necessary,	and	could	be	accomplished	by	running	healthy	volunteers	under	the	same	conditions	over	many	days	to	examine	the	time-to-plateau.		 	
CONCLUSION	
	 Mobile	sensing	actigraphy	has	been	demonstrated	as	a	viable	alternative	to	traditional	force	plate	posturography.	The	BioSensics®	sensors,	using	a	two-link	biomechanical	model,	exhibited	similar	patterns	of	Equilibrium	Score	and	Sway	Velocity	as	compared	to	the	NeuroCom®	SMART	Balance	Master	system.	This	study	showed	strong-to-moderate	consistency	between	the	systems,	depending	on	the	endpoint.	Further	investigation	into	practice	effects,	subject	confounds	in	drug	research,	and	the	optimal	number	and	placement	of	sensors	is	necessary	before	mobile	sensing	has	enough	validity	and	reliability	to	be	used	in	the	clinical	environment.	Replication	of	this	study	with	a	greater	number	of	participants	is	recommended.		 	
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________________                                                                                                                                                   
Education 
The University of Maine at Farmington, Farmington, ME 
Bachelor of Arts, Business Psychology                       
December 2014 
• Northeast Undergraduate Research & Development Symposium, 
Best Oral Presentation 
• UMF Research Symposium, Select Speaker Award for Research 
Study –  
“Inducing Relaxation via Virtual Reality” 
• Relevant Coursework: Abnormal Psychology, Research Methods 
& Design, Organizational Psychology, Human Resources 
Management 
________________________________________________________________
________________	
Research Experience 
 
• “A Multimodal Evaluation of Circadian Rhythm”  
Central Role: Data Acquisition & Management 
o Device Management - Responsible for actigraphy device 
configuration, troubleshooting, data upload, file management, and 
vendor communication. 
o Data analysis – Responsible for formatting data architecture and 
producing analyses of circadian patterns using “RADA” software 
(Rapid Actigraphy Data Analysis, Philips). 
o Data Management – Responsible for file architecture management, 
quality assurance of data integrity, and database management. 
 
• “Evaluation of a Mobile Application and Two Actigraphy Devices in 
Subjects with Parkinson’s Disease and Healthy Volunteers” 
Central Role: Study Coordinator 
o Subject Management - Responsible for recruitment, screening, and 
scheduling of participants, in collaboration with the Michael J. Fox 
Foundation. Responsible for administration of clinical and 
psychometric assessments. 
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o Device Management – Responsible for device configuration, 
maintenance, and troubleshooting, along with data upload and 
storage. 
o Staff Management – Responsible for staff training, scheduling, 
management, and coordination. 
________________________________________________________________
________________	
Awards 
• Northeast Undergraduate Research & Development Symposium 
o Best Presentation; “Inducing Relaxation via Virtual Reality” 
o University of New England, April 2014 
 
• University of Maine at Farmington Research Symposium 
o Select Speaker Award 
o UMF, May 2014 
 
• Rotary Youth Leadership Award 
o Mount St. Mary College, July 2009 
 
